Assessment of Public Opinion on Transparency at the US Food and Drug Administration

被引：3
|
作者：
Azad, Tej D. [1 ]
Plott, Caroline F. [2 ]
Gielen, Andrea C. [3 ]
Sharfstein, Joshua M. [4 ]
机构：
[1] Johns Hopkins Univ Hosp, Dept Neurosurg, Baltimore, MD 21287 USA
[2] Johns Hopkins Sch Med, Baltimore, MD USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 615 N Wolfe St,W1033F, Baltimore, MD 21205 USA
来源：
JAMA NETWORK OPEN | 2022年 / 5卷 / 02期
关键词：
D O I：
10.1001/jamanetworkopen.2022.0026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Moving the US Food and Drug Administration Forward
    Perlmutter, Joel S.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (11) : 1626 - 1627
  • [32] Cyberpharmacies and the role of the US Food And Drug Administration
    Henney, Jane E.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2001, 3 (01) : 7 - 20
  • [33] The US Food and Drug Administration and Emergency Contraception
    Anthony W. Fox
    International Journal of Pharmaceutical Medicine, 2005, 19 (3) : 139 - 140
  • [34] Opportunities and Challenges for the US Food And Drug Administration
    Kavanaugh, Claudine J.
    JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS, 2009, 2 (4-5) : 203 - 203
  • [35] US Food and Drug Administration regulation of color additives in food
    Barrows, Julie N.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [36] Enhancing Transparency at the US Food and Drug Administration Moving Beyond the 21st Century Cures Act
    Sharfstein, Joshua M.
    Stebbins, Michael
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (16): : 1621 - 1622
  • [37] Nuclear methods for food analysis at the US Food and Drug Administration
    Anderson, DL
    Cunningham, WC
    Capar, SG
    Baratta, EJ
    Mackill, P
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2001, 249 (01) : 29 - 32
  • [38] Regulatory Research to Support Food-Contact Infant Safety Assessment at US Food and Drug Administration
    Neal-Kluever, A. P.
    Aungst, J.
    Wu, Y.
    Liu, J.
    Shackelford, M.
    Ogungbesan, A.
    Gu, Y.
    Jacobs, K.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2016, 106 (05) : 404 - 404
  • [39] Exposure-Response Assessment in Pediatric Drug Development Studies Submitted to the US Food and Drug Administration
    Zhang, Yifei
    Wang, Yaning
    Khurana, Mona
    Sachs, Hari Cheryl
    Zhu, Hao
    Burckart, Gilbert J.
    Alexander, John
    Yao, Lynne P.
    Wang, Jian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (01) : 90 - 98
  • [40] US Food and Drug Administration and Design of Drug Approval Studies
    Woloshin, Steven
    Schwartz, Lisa M.
    Frankel, Brittney
    Faerber, Adrienne
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (20): : 2163 - 2165
12345